Article

2012 Technology Innovator of the Year: Stephen Vogt

Stephen Vogt, PharmD, endeavors to create personalized treatment strategies for each patient.

This video features Stephen Vogt, PharmD, who won the 2012 Next-Generation Pharmacist Technology Innovator of the Year award, presented by Pharmacy Times and Parata Systems. Dr. Vogt is owner of BioPlus Specialty Pharmacy in Altamonte Springs, FL, where he endeavors to create personalized treatment strategies for each patient. To read more about Dr. Vogt, click here.

Related Videos
Image credit: Photo18@desing | stock.dobe.com
Related Content
A scientist in sterile coverall gown pipetting medium or reagents for cell culture experiment in biological safety cabinet. Doing biological research in clean environmental.
April 30th 2025

Asembia AXS25: Cell and Gene Therapies Enter New Phase of Growth in Specialty Pharmacy

Luke Halpern, Assistant Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
FDA Approves Prademagene Zamikeracel, First and Only Cell-Based Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa
April 29th 2025

FDA Approves Prademagene Zamikeracel, First and Only Cell-Based Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa

Aislinn Antrim, Managing Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Take Charge of Hypertension: Essential Steps for Better Health
April 29th 2025

Take Charge of Hypertension: Essential Steps for Better Health

Melissa Russo, PharmD
Two African American pharmacists working in drugstore at hospital pharmacy | Image Credit: © AS Photo Family - stock.adobe.com
April 29th 2025

Asembia AXS25: Balancing Innovation With Affordability Crucial for Sustainable Rare Disease Economic Models

Luke Halpern, Assistant Editor